https://feeds.blubrry.com/feeds/1469362.xml PayerTalkCE https://www.impactedu.net https://www.impactedu.net Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours. episodic IMPACT Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours. podcast en Copyright 2026 PayerTalkCE Copyright 2026 PayerTalkCE IMPACT itunes@impactedu.net https://www.impactedu.net https://assets.blubrry.com/coverart/orig/1469362-1665078228.jpg PayerTalkCE PayerTalkCE provides continuing education podcasts for managed care and payer professionals. Visit www.impactedu.net for more information. Blubrry Podcasting: https://www.blubrry.com/ false http://blogs.law.harvard.edu/tech/rss 41677a16-b02a-5acd-940f-9c4aa5119715 Wed, 18 Jun 2025 16:00:00 -0400 Wed, 18 Jun 2025 16:00:00 -0400 PayerTalkCE® Presents: Emerging HER2-targeting Therapies for the Management of GI Cancers 10 https://www.impactedu.net/gi-cancer-management/ https://blubrry.com/1469362/146146587/payertalkce-presents-emerging-her2-targeting-therapies-for-the-management-of-gi-cancers/ IMPACT Wed, 18 Jun 2025 16:00:00 -0400 In this episode of PayerTalkCE®, we will delve into the innovations around HER2-targeting therapies and their role in the treatment of select gastrointestinal cancers. Topics will include the latest evidence and the integration of new treatments into health care systems, insurance coverage, reimbursement challenges, and the overall impact on health care policy.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/gi-cancer-ce/.

]]> 0:31:04 false IMPACT In this episode of PayerTalkCE®, we will delve into the innovations around HER2-targeting therapies and their role in the treatment of select gastrointestinal cancers. Topics will include the latest evidence and the integration of new treatments into health care systems, insurance coverage, reimbursement challenges, and the overall impact on health care policy.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/gi-cancer-ce/. PayerTalkCE® Presents: Emerging HER2-targeting Therapies for the Management of GI Cancers 3 10 full 10 https://assets.blubrry.com/coverart/episode/1469362/orig/146146587-1749578367.jpg 3 PayerTalkCE® Presents: Trends in Cancer Care: Precision Oncology in Rare GI Cancers 11 https://blubrry.com/1469362/146146588/payertalkce-presents-trends-in-cancer-care-precision-oncology-in-rare-gi-cancers/ https://blubrry.com/1469362/146146588/payertalkce-presents-trends-in-cancer-care-precision-oncology-in-rare-gi-cancers/ IMPACT Wed, 18 Jun 2025 14:00:00 -0400 In this episode of PayerTalkCE® we will explore the epidemiology and burdens of gastroesophageal and biliary tract cancers. Experts will discuss the importance of early and accurate diagnosis in managing treatment efficacy and cost. The episode will also delve into the role of personalized medicine and multidisciplinary approaches and provide collaborative and actionable insights on how managed care professionals can adapt their strategies to better accommodate the complexities associated with rare GI cancers, ultimately aiming to enhance patient care while managing resource allocation effectively.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/gi-trends-ce/.

]]> 0:30:30 false IMPACT In this episode of PayerTalkCE® we will explore the epidemiology and burdens of gastroesophageal and biliary tract cancers. Experts will discuss the importance of early and accurate diagnosis in managing treatment efficacy and cost. The episode will also delve into the role of personalized medicine and multidisciplinary approaches and provide collaborative and actionable insights on how managed care professionals can adapt their strategies to better accommodate the complexities associated with rare GI cancers, ultimately aiming to enhance patient care while managing resource allocation effectively.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/gi-trends-ce/. PayerTalkCE® Presents: Trends in Cancer Care: Precision Oncology in Rare GI Cancers 3 11 full 11 https://assets.blubrry.com/coverart/episode/1469362/orig/146146588-1749578583.jpg 3 PayerTalkCE® Presents: Managed Care Strategies to Improve Outcomes for Macular Telangiectasia 9 https://blubrry.com/1469362/145036167/payertalkce-presents-managed-care-strategies-to-improve-outcomes-for-macular-telangiectasia/ https://blubrry.com/1469362/145036167/payertalkce-presents-managed-care-strategies-to-improve-outcomes-for-macular-telangiectasia/ IMPACT Thu, 01 May 2025 00:03:00 -0400 This podcast explores macular telangiectasia (MacTel), a rare and progressive retinal disease, with a focus on advancing early detection, appropriate treatment, and health system coordination. Retina specialist Dr. Jay Chhablani discusses the shift in understanding MacTel as a neurodegenerative—not vascular—condition, highlighting the limitations of anti-VEGF therapy and the significance of a newly approved, durable implant that targets neuroprotection. The discussion outlines the importance of benefit design that facilitates timely access, supports multidisciplinary care, and emphasizes early intervention to prevent irreversible vision loss. Practical payer strategies—including reducing artificial barriers and prioritizing education—are addressed to optimize outcomes.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/mactel-strategies-ce/.

]]> 0:52:46 false IMPACT This podcast explores macular telangiectasia (MacTel), a rare and progressive retinal disease, with a focus on advancing early detection, appropriate treatment, and health system coordination. Retina specialist Dr. Jay Chhablani discusses the shift in understanding MacTel as a neurodegenerative—not vascular—condition, highlighting the limitations of anti-VEGF therapy and the significance of a newly approved, durable implant that targets neuroprotection. The discussion outlines the importance of benefit design that facilitates timely access, supports multidisciplinary care, and emphasizes early intervention to prevent irreversible vision loss. Practical payer strategies—including reducing artificial barriers and prioritizing education—are addressed to optimize outcomes.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/mactel-strategies-ce/. PayerTalkCE® Presents: Managed Care Strategies to Improve Outcomes for Macular Telangiectasia 3 9 full 9 https://assets.blubrry.com/coverart/episode/1469362/orig/145036167-1746020098.jpg 3 PayerTalkCE® Presents: Understanding T2 Inflammation: Best Practices in COPD Management 8 https://www.impactedu.net/type2-inflammation-copd-management-ce/ https://blubrry.com/1469362/144991697/payertalkce-presents-understanding-t2-inflammation-best-practices-in-copd-management/ IMPACT Thu, 01 May 2025 00:02:00 -0400 This podcast highlights opportunities for managed care organizations to improve COPD management by aligning coverage policies with current clinical evidence and treatment guidelines. Experts discuss new therapies, including recently approved biologics and inhaled agents, and their roles in treating patients with frequent exacerbations or type 2 inflammation. The session also addresses implementation barriers such as limited spirometry access, inconsistent pulmonary rehab availability, and disparities in care. Strategies for payer engagement include expanding telehealth, integrating social determinants of health data, enhancing care coordination, and supporting multidisciplinary care models to reduce hospitalizations and improve outcomes in patients with moderate to severe COPD.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/type2-inflammation-copd-management-ce/.

]]> 0:53:00 false IMPACT This podcast highlights opportunities for managed care organizations to improve COPD management by aligning coverage policies with current clinical evidence and treatment guidelines. Experts discuss new therapies, including recently approved biologics and inhaled agents, and their roles in treating patients with frequent exacerbations or type 2 inflammation. The session also addresses implementation barriers such as limited spirometry access, inconsistent pulmonary rehab availability, and disparities in care. Strategies for payer engagement include expanding telehealth, integrating social determinants of health data, enhancing care coordination, and supporting multidisciplinary care models to reduce hospitalizations and improve outcomes in patients with moderate to severe COPD.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/type2-inflammation-copd-management-ce/. PayerTalkCE® Presents: Understanding T2 Inflammation: Best Practices in COPD Management 3 8 full 8 https://assets.blubrry.com/coverart/episode/1469362/orig/144991697-1745851166.jpg 3 PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on COPD 7 https://www.impactedu.net/type2-inflammation-copd-management/ https://blubrry.com/1469362/144991352/payertalkce-presents-understanding-type-2-inflammation-spotlight-on-copd/ IMPACT Thu, 01 May 2025 00:00:00 -0400 This podcast features expert discussion on the emerging role of type 2 (T2) inflammation in chronic obstructive pulmonary disease (COPD) and the implications for payer and provider decision-making. Faculty review key pathophysiologic mechanisms and biomarkers—particularly eosinophil counts—that identify patients most likely to benefit from targeted biologic therapies. The conversation also explores updated GOLD guideline recommendations, strategies to optimize formulary access, the impact of T2 inflammation on long-term outcomes, and opportunities to reduce hospitalizations and oral steroid use. Health plan professionals will gain insights into aligning policies with evolving clinical evidence and enhancing care coordination to improve outcomes.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/type2-inflammation-copd-management/.

]]> 0:55:34 false IMPACT This podcast features expert discussion on the emerging role of type 2 (T2) inflammation in chronic obstructive pulmonary disease (COPD) and the implications for payer and provider decision-making. Faculty review key pathophysiologic mechanisms and biomarkers—particularly eosinophil counts—that identify patients most likely to benefit from targeted biologic therapies. The conversation also explores updated GOLD guideline recommendations, strategies to optimize formulary access, the impact of T2 inflammation on long-term outcomes, and opportunities to reduce hospitalizations and oral steroid use. Health plan professionals will gain insights into aligning policies with evolving clinical evidence and enhancing care coordination to improve outcomes.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/type2-inflammation-copd-management/. PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on COPD 3 7 full 7 https://assets.blubrry.com/coverart/episode/1469362/orig/144991352-1745850593.jpg 3 PayerTalkCE® Presents: Case Challenge: Age-Related Macular Degeneration 6 https://www.managedcareeye.com/amd-case-challenge-ce/ https://blubrry.com/1469362/143177391/payertalkce-presents-case-challenge-age-related-macular-degeneration/ IMPACT Tue, 01 Apr 2025 00:02:00 -0400 This podcast reviews a case-based discussion on managing age-related macular degeneration (AMD), a leading cause of blindness among older adults, particularly those enrolled in Medicare Advantage plans. Experts review the progression of AMD, key diagnostic tools, and the importance of timely anti-VEGF therapy to prevent vision loss. The conversation highlights payer considerations, including step therapy requirements, treatment burden, and long-term cost implications. It also addresses challenges such as healthcare access in rural areas and potential strategies for improving patient adherence and outcomes. The discussion underscores the need for balanced policies that optimize clinical efficacy and economic sustainability.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.managedcareeye.com/amd-case-challenge-ce/.

]]> 0:31:33 false IMPACT This podcast reviews a case-based discussion on managing age-related macular degeneration (AMD), a leading cause of blindness among older adults, particularly those enrolled in Medicare Advantage plans. Experts review the progression of AMD, key diagnostic tools, and the importance of timely anti-VEGF therapy to prevent vision loss. The conversation highlights payer considerations, including step therapy requirements, treatment burden, and long-term cost implications. It also addresses challenges such as healthcare access in rural areas and potential strategies for improving patient adherence and outcomes. The discussion underscores the need for balanced policies that optimize clinical efficacy and economic sustainability.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/amd-case-challenge-ce/. PayerTalkCE® Presents: Case Challenge: Age-Related Macular Degeneration 3 6 full 6 https://assets.blubrry.com/coverart/episode/1469362/orig/143177391-1741717513.jpg 3 PayerTalkCE® Presents: Case Challenge: T1 Diabetes Patient with Diabetic Retinopathy 5 https://www.managedcareeye.com/t1-diabetes-case/ https://blubrry.com/1469362/142990784/payertalkce-presents-case-challenge-t1-diabetes-patient-with-diabetic-retinopathy/ IMPACT Tue, 01 Apr 2025 00:01:00 -0400 This podcast explores the challenges of managing diabetic retinopathy in patients with type 1 diabetes, focusing on a case study of a working-age patient with barriers to care. Expert insights highlight the importance of early screening, timely intervention, and payer strategies to facilitate access to specialty care. Discussion covers diagnostic approaches, treatment selection, and the role of anti-VEGF therapies, including considerations around step therapy and treatment adherence. The conversation emphasizes the impact of social determinants on care continuity and explores how health plans can improve patient outcomes through streamlined authorization processes and better care coordination within multidisciplinary teams.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.managedcareeye.com/t1-diabetes-case/.

]]> 0:29:24 false IMPACT This podcast explores the challenges of managing diabetic retinopathy in patients with type 1 diabetes, focusing on a case study of a working-age patient with barriers to care. Expert insights highlight the importance of early screening, timely intervention, and payer strategies to facilitate access to specialty care. Discussion covers diagnostic approaches, treatment selection, and the role of anti-VEGF therapies, including considerations around step therapy and treatment adherence. The conversation emphasizes the impact of social determinants on care continuity and explores how health plans can improve patient outcomes through streamlined authorization processes and better care coordination within multidisciplinary teams.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/t1-diabetes-case/. PayerTalkCE® Presents: Case Challenge: T1 Diabetes Patient with Diabetic Retinopathy 3 5 full 5 https://assets.blubrry.com/coverart/episode/1469362/orig/142990784-1741378642.jpg 3 PayerTalkCE® Presents: Understanding Type 2 Inflammation: Best Practices in Moderate-to-Severe Asthma Management 4 https://www.impactedu.net/type2-inflammation-asthma-management-ce/. https://blubrry.com/1469362/142250417/payertalkce-presents-understanding-type-2-inflammation-best-practices-in-moderate-to-severe-asthma-management/ IMPACT Sat, 01 Mar 2025 00:05:00 -0500 This podcast provides health plan professionals with expert insights on best practices for managing moderate to severe asthma, focusing on type 2 inflammation. Discussion topics include current treatment guidelines, the role of biomarkers in therapy selection, and the impact of biologics on reducing exacerbations and healthcare utilization. Experts also examine challenges in asthma management, such as adherence barriers, care fragmentation, and affordability, while highlighting opportunities for payers to support multidisciplinary care and improve patient outcomes. The conversation underscores the importance of collaboration between payers and providers to ensure appropriate utilization of therapies and enhance access to high-quality asthma care.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/type2-inflammation-asthma-management-ce/.

]]> 0:51:40 false IMPACT This podcast provides health plan professionals with expert insights on best practices for managing moderate to severe asthma, focusing on type 2 inflammation. Discussion topics include current treatment guidelines, the role of biomarkers in therapy selection, and the impact of biologics on reducing exacerbations and healthcare utilization. Experts also examine challenges in asthma management, such as adherence barriers, care fragmentation, and affordability, while highlighting opportunities for payers to support multidisciplinary care and improve patient outcomes. The conversation underscores the importance of collaboration between payers and providers to ensure appropriate utilization of therapies and enhance access to high-quality asthma care.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/type2-inflammation-asthma-management-ce/. PayerTalkCE® Presents: Understanding Type 2 Inflammation: Best Practices in Moderate-to-Severe Asthma Management 3 4 full 4 https://assets.blubrry.com/coverart/episode/1469362/orig/142250417-1739809350.jpg 3 PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on Moderate-to-Severe Asthma 3 https://www.impactedu.net/type2-inflammation-asthma-management-ce/ https://blubrry.com/1469362/142250245/payertalkce-presents-understanding-type-2-inflammation-spotlight-on-moderate-to-severe-asthma/ IMPACT Sat, 01 Mar 2025 00:02:00 -0500 This podcast provides health plan professionals with an in-depth discussion on the role of type 2 (T2) inflammation in asthma pathophysiology and the evolving treatment landscape. Experts explore the mechanisms driving T2 inflammation and how biomarkers can help guide therapy selection. The conversation highlights biologic treatments' clinical and economic considerations, including their impact on reducing exacerbations, optimizing outcomes, and managing healthcare costs. Panelists also discuss payer strategies for ensuring appropriate utilization, balancing financial stewardship with patient access, and the importance of collaboration between payers and providers to improve asthma care and reduce healthcare resource utilization.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at

https://www.impactedu.net/type2-inflammation-asthma-management-ce/.

]]> 0:50:27 false IMPACT This podcast provides health plan professionals with an in-depth discussion on the role of type 2 (T2) inflammation in asthma pathophysiology and the evolving treatment landscape. Experts explore the mechanisms driving T2 inflammation and how biomarkers can help guide therapy selection. The conversation highlights biologic treatments' clinical and economic considerations, including their impact on reducing exacerbations, optimizing outcomes, and managing healthcare costs. Panelists also discuss payer strategies for ensuring appropriate utilization, balancing financial stewardship with patient access, and the importance of collaboration between payers and providers to improve asthma care and reduce healthcare resource utilization.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.impactedu.net/type2-inflammation-asthma-management-ce/. PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on Moderate-to-Severe Asthma 3 3 full 3 https://assets.blubrry.com/coverart/episode/1469362/orig/142250245-1739809053.jpg 3 PayerTalkCE® Presents: Understanding Type 2 Inflammation: Best Practices in Atopic Dermatitis Management 2 https://www.impactedu.net/type2-inflammation-atopic-dermatitis-management. https://blubrry.com/1469362/140457843/payertalkce-presents-understanding-type-2-inflammation-best-practices-in-atopic-dermatitis-management/ IMPACT Fri, 31 Jan 2025 00:02:00 -0500 This podcast explores payer best practices in managing atopic dermatitis, emphasizing the role of type 2 inflammation and its impact on patient outcomes. Experts discuss current treatment guidelines, the efficacy of emerging therapies, and strategies for tailoring care to patient needs, including those with darker skin tones. Key barriers such as access to dermatologists, treatment complexity, and psychosocial impacts are highlighted, with insights on payer strategies to improve access and affordability. Topics include clinical guidelines, innovative payer programs, formulary management, and value-based contracting to enhance care quality while controlling costs.


This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at

https://www.impactedu.net/type2-inflammation-atopic-dermatitis-management-ce/.

]]> 0:45:33 false IMPACT This podcast explores payer best practices in managing atopic dermatitis, emphasizing the role of type 2 inflammation and its impact on patient outcomes. Experts discuss current treatment guidelines, the efficacy of emerging therapies, and strategies for tailoring care to patient needs, including those with darker skin tones. Key barriers such as access to dermatologists, treatment complexity, and psychosocial impacts are highlighted, with insights on payer strategies to improve access and affordability. Topics include clinical guidelines, innovative payer programs, formulary management, and value-based contracting to enhance care quality while controlling costs.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.impactedu.net/type2-inflammation-atopic-dermatitis-management-ce/. PayerTalkCE® Presents: Understanding Type 2 Inflammation: Best Practices in Atopic Dermatitis Management 3 2 full 2 https://assets.blubrry.com/coverart/episode/1469362/orig/140457843-1735828192.jpg 3 PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on Atopic Dermatitis 1 https://www.impactedu.net/type2-inflammation-atopic-dermatitis-management. https://blubrry.com/1469362/140457686/payertalkce-presents-understanding-type-2-inflammation-spotlight-on-atopic-dermatitis/ IMPACT Fri, 31 Jan 2025 00:01:00 -0500 This podcast provides an in-depth exploration of type 2 inflammation and its role in the pathophysiology and management of atopic dermatitis, tailored for health plan professionals. Experts discuss the molecular mechanisms driving the condition, including key cytokines like IL-4 and IL-13, and highlight the clinical and quality-of-life impacts for patients. The conversation covers the evolution of targeted therapies, including biologics and JAK inhibitors, and emphasizes the importance of shared decision-making and timely treatment. Special attention is given to addressing health disparities in diagnosing and treating patients with darker skin tones, underscoring the need for equitable care strategies.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

https://www.impactedu.net/type2-inflammation-atopic-dermatitis-management-ce/.

]]> 0:42:05 false IMPACT This podcast provides an in-depth exploration of type 2 inflammation and its role in the pathophysiology and management of atopic dermatitis, tailored for health plan professionals. Experts discuss the molecular mechanisms driving the condition, including key cytokines like IL-4 and IL-13, and highlight the clinical and quality-of-life impacts for patients. The conversation covers the evolution of targeted therapies, including biologics and JAK inhibitors, and emphasizes the importance of shared decision-making and timely treatment. Special attention is given to addressing health disparities in diagnosing and treating patients with darker skin tones, underscoring the need for equitable care strategies.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.impactedu.net/type2-inflammation-atopic-dermatitis-management-ce/. PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on Atopic Dermatitis 3 1 full 1 https://assets.blubrry.com/coverart/episode/1469362/orig/140457686-1735828086.jpg 3 PayerTalkCE® Presents: Managing DR/DME for Underserved Populations 9 https://www.managedcareeye.com/managing-dr-dme-ce https://blubrry.com/1469362/139308729/payertalkce-presents-managing-drdme-for-underserved-populations/ IMPACT Tue, 31 Dec 2024 00:03:00 -0500 This PayerTalkCE podcast, hosted by Dana McCormick and Dr. Jordan Graff, focuses on managing diabetic retinopathy (DR) and diabetic macular edema (DME) in underserved populations. Key challenges include limited access to care, transportation, and socioeconomic barriers. They highlight the importance of early intervention, remote screening technologies, and advancements in anti-VEGF therapies to reduce treatment burden and improve outcomes. Discussions emphasize balancing the cost of newer, more effective treatments with their ability to reduce the frequency of visits and improve patient adherence. Collaboration between payers and providers is critical to enhance access, manage costs, and optimize care for vulnerable populations.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

https://www.managedcareeye.com/managing-dr-dme-ce/.

]]> 0:27:36 false IMPACT This PayerTalkCE podcast, hosted by Dana McCormick and Dr. Jordan Graff, focuses on managing diabetic retinopathy (DR) and diabetic macular edema (DME) in underserved populations. Key challenges include limited access to care, transportation, and socioeconomic barriers. They highlight the importance of early intervention, remote screening technologies, and advancements in anti-VEGF therapies to reduce treatment burden and improve outcomes. Discussions emphasize balancing the cost of newer, more effective treatments with their ability to reduce the frequency of visits and improve patient adherence. Collaboration between payers and providers is critical to enhance access, manage costs, and optimize care for vulnerable populations.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.managedcareeye.com/managing-dr-dme-ce/. PayerTalkCE® Presents: Managing DR/DME for Underserved Populations 2 9 full 9 https://assets.blubrry.com/coverart/episode/1469362/orig/139308729-1733343968.jpg 2 PayerTalkCE® Presents: Care Coordination for a Patient with AMD and Multiple Comorbid Conditions 8 https://www.managedcareeye.com/amd-care-coordination-ce https://blubrry.com/1469362/139308477/payertalkce-presents-care-coordination-for-a-patient-with-amd-and-multiple-comorbid-conditions/ IMPACT Tue, 31 Dec 2024 00:02:00 -0500 In this PayerTalkCE podcast, Dr. Gary Owens and Dr. Adrienne Scott discuss the care coordination challenges and treatment strategies for patients with age-related macular degeneration (AMD) and comorbid conditions like hypertension and diabetes. They emphasize the importance of individualized therapy, including treat-and-extend protocols and balancing treatment burden with efficacy. Key challenges include patient adherence, travel burden, and out-of-pocket costs. They explore payer roles in supporting patient care through formulary flexibility, feedback on prescribing patterns, and patient support services. The conversation highlights collaboration between payers and providers to optimize outcomes and cost-effectiveness for patients with AMD.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

 https://www.managedcareeye.com/amd-care-coordination-ce/.

]]> 0:27:47 false IMPACT In this PayerTalkCE podcast, Dr. Gary Owens and Dr. Adrienne Scott discuss the care coordination challenges and treatment strategies for patients with age-related macular degeneration (AMD) and comorbid conditions like hypertension and diabetes. They emphasize the importance of individualized therapy, including treat-and-extend protocols and balancing treatment burden with efficacy. Key challenges include patient adherence, travel burden, and out-of-pocket costs. They explore payer roles in supporting patient care through formulary flexibility, feedback on prescribing patterns, and patient support services. The conversation highlights collaboration between payers and providers to optimize outcomes and cost-effectiveness for patients with AMD.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/amd-care-coordination-ce/. PayerTalkCE® Presents: Care Coordination for a Patient with AMD and Multiple Comorbid Conditions 2 8 full 8 https://assets.blubrry.com/coverart/episode/1469362/orig/139308477-1733343549.jpg 2 PayerTalkCE™ Presents: Understanding Type 2 Inflammation: Best Practices in EoE Management 7 https://www.impactedu.net/type2-inflammation-eoe-management https://blubrry.com/1469362/138172621/payertalkce-presents-understanding-type-2-inflammation-best-practices-in-eoe-management/ IMPACT Fri, 29 Nov 2024 23:59:00 -0500 In this discussion, Dana McCormick, RPh, introduces a CE program on managing eosinophilic esophagitis (EoE) with insights from Dr. Evan Dellon and Dr. Drake Reiter. Dr. Dellon highlights advancements in EoE treatment guidelines, including new pharmacologic options, and stresses individualized care strategies. Dr. Reiter emphasizes the value of clinical guidelines for payers in managing EoE, aligning formularies, and supporting optimal outcomes. They discuss barriers to EoE care, such as access to specialists, insurance coverage, and treatment costs. They also explore potential solutions like telehealth, patient education, and payer-supported multidisciplinary care models to improve accessibility and efficiency in EoE management.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

https://www.impactedu.net/type2-inflammation-eoe-management.

]]> 0:49:58 false IMPACT In this discussion, Dana McCormick, RPh, introduces a CE program on managing eosinophilic esophagitis (EoE) with insights from Dr. Evan Dellon and Dr. Drake Reiter. Dr. Dellon highlights advancements in EoE treatment guidelines, including new pharmacologic options, and stresses individualized care strategies. Dr. Reiter emphasizes the value of clinical guidelines for payers in managing EoE, aligning formularies, and supporting optimal outcomes. They discuss barriers to EoE care, such as access to specialists, insurance coverage, and treatment costs. They also explore potential solutions like telehealth, patient education, and payer-supported multidisciplinary care models to improve accessibility and efficiency in EoE management.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.impactedu.net/type2-inflammation-eoe-management. PayerTalkCE™ Presents: Understanding Type 2 Inflammation: Best Practices in EoE Management 2 7 full 7 https://assets.blubrry.com/coverart/episode/1469362/orig/138172621-1730747235.jpg 2 PayerTalkCE™ Presents: Understanding Type 2 Inflammation - Spotlight on Eosinophilic Esophagitis 6 https://www.impactedu.net/type2-inflammation-eoe-management https://blubrry.com/1469362/137767871/payertalkce-presents-understanding-type-2-inflammation-spotlight-on-eosinophilic-esophagitis/ IMPACT Fri, 29 Nov 2024 00:00:00 -0500 This podcast addresses the role of type 2 inflammation in the pathophysiology and management of eosinophilic esophagitis (EoE), with a focus on evolving treatment strategies. Dr. Evan Dellon discusses the mechanisms behind EoE, the limitations of current allergy testing, and the challenges in diagnosing the condition due to non-specific symptoms. He reviews current therapeutic approaches, including dietary modifications, proton pump inhibitors, topical steroids, and biologics like dupilumab, which target specific inflammatory pathways. Emerging therapies and combination treatments are also explored, highlighting opportunities for optimizing patient outcomes in this chronic condition.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

https://www.impactedu.net/type2-inflammation-eoe-management.

]]> 0:36:49 false IMPACT This podcast addresses the role of type 2 inflammation in the pathophysiology and management of eosinophilic esophagitis (EoE), with a focus on evolving treatment strategies. Dr. Evan Dellon discusses the mechanisms behind EoE, the limitations of current allergy testing, and the challenges in diagnosing the condition due to non-specific symptoms. He reviews current therapeutic approaches, including dietary modifications, proton pump inhibitors, topical steroids, and biologics like dupilumab, which target specific inflammatory pathways. Emerging therapies and combination treatments are also explored, highlighting opportunities for optimizing patient outcomes in this chronic condition.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.impactedu.net/type2-inflammation-eoe-management. PayerTalkCE™ Presents: Understanding Type 2 Inflammation - Spotlight on Eosinophilic Esophagitis 2 6 full 6 https://assets.blubrry.com/coverart/episode/1469362/orig/137767871-1729626164.jpg 2 PayerTalkCE™ Presents: Advancing Equity: Pediatric Atopic Dermatitis Management in Managed Care 5 https://www.impactedu.net/atopic-dermatitis-pediatric-management https://blubrry.com/1469362/137294558/payertalkce-presents-advancing-equity-pediatric-atopic-dermatitis-management-in-managed-care/ IMPACT Fri, 01 Nov 2024 00:00:00 -0400 This podcast focuses on improving equity in pediatric atopic dermatitis management, highlighting key challenges in access to care for children with moderate to severe cases. Dr. Joy Wan emphasizes the importance of timely referrals to dermatologists, noting the frustrations families face due to delays in treatment. She discusses the complexities of treatment, considering safety, efficacy, and the individual needs of children. The discussion also underscores the psychosocial impact of atopic dermatitis, including sleep disruption and mental health concerns. Payers are encouraged to adapt policies that consider these unique challenges to ensure appropriate access and support for families managing this chronic condition.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopic-dermatitis-pediatric-management.

]]> 0:31:57 false IMPACT This podcast focuses on improving equity in pediatric atopic dermatitis management, highlighting key challenges in access to care for children with moderate to severe cases. Dr. Joy Wan emphasizes the importance of timely referrals to dermatologists, noting the frustrations families face due to delays in treatment. She discusses the complexities of treatment, considering safety, efficacy, and the individual needs of children. The discussion also underscores the psychosocial impact of atopic dermatitis, including sleep disruption and mental health concerns. Payers are encouraged to adapt policies that consider these unique challenges to ensure appropriate access and support for families managing this chronic condition.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopic-dermatitis-pediatric-management. PayerTalkCE™ Presents: Advancing Equity: Pediatric Atopic Dermatitis Management in Managed Care 2 5 full 5 https://assets.blubrry.com/coverart/episode/1469362/orig/137294558-1728582561.jpg 2 PayerTalkCE™ Presents: Diabetes Quality Management–Trends and Opportunities for Continuous Glucose Monitoring in Managed Care Pharmacy 4 https://www.managedcarecgm.com/diabetes-quality-and-cgm https://blubrry.com/1469362/132653479/payertalkce-presents-diabetes-quality-managementtrends-and-opportunities-for-continuous-glucose-monitoring-in-managed-care-pharmacy/ IMPACT Fri, 31 May 2024 23:57:00 -0400 The podcast features an expert panel discussing trends and opportunities for continuous glucose monitoring (CGM) in managing diabetes within managed care. Dr. Timothy Gilbert emphasizes technological advancements in CGM, illustrating benefits in improving glycemic control and reducing diabetes-related complications. The conversation highlights CGM's role in patient engagement by providing real-time data to manage diabetes effectively. Dr. Maureen Hennessey discusses the integration of CGM into quality measures like HEDIS, focusing on its potential to enhance diabetes care and address health disparities. Susan Wescott and Sean Chitwood elaborate on health plan best practices, financial benefits, and the impact of CGM on quality metrics.



This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

https://www.managedcarecgm.com/diabetes-quality-and-cgm.

]]> 1:05:06 false IMPACT The podcast features an expert panel discussing trends and opportunities for continuous glucose monitoring (CGM) in managing diabetes within managed care. Dr. Timothy Gilbert emphasizes technological advancements in CGM, illustrating benefits in improving glycemic control and reducing diabetes-related complications. The conversation highlights CGM's role in patient engagement by providing real-time data to manage diabetes effectively. Dr. Maureen Hennessey discusses the integration of CGM into quality measures like HEDIS, focusing on its potential to enhance diabetes care and address health disparities. Susan Wescott and Sean Chitwood elaborate on health plan best practices, financial benefits, and the impact of CGM on quality metrics.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.managedcarecgm.com/diabetes-quality-and-cgm (https://www.managedcarecgm.com/diabetes-quality-and-cgm). PayerTalkCE™ Presents: Diabetes Quality Management–Trends and Opportunities for Continuous Glucose Monitoring in Managed Care Pharmacy 2 4 full 4 2 PayerTalkCE™ Presents: Current Strategies to Optimize Clinical, Economic, and Humanistic Outcomes in Multiple Sclerosis 3 https://www.impactedu.net/ms-current-strategies https://blubrry.com/1469362/132601689/payertalkce-presents-current-strategies-to-optimize-clinical-economic-and-humanistic-outcomes-in-multiple-sclerosis/ IMPACT Fri, 31 May 2024 23:56:00 -0400 This PayerTalkCE episode provides an in-depth examination of the management and treatment of Multiple Sclerosis (MS) from both a clinical and payer perspective. Experts discuss various MS subtypes, emphasizing the importance of tailored treatments based on individual patient needs and disease progression. Key considerations include drug efficacy, side effects, comorbidities, and the economic aspects such as cost-effectiveness and payer coverage. The conversation highlights the challenges and strategies in optimizing treatment pathways, navigating benefit design complexities, and the potential of personalized medicine in improving patient outcomes. The discussion is highly relevant for health plan professionals, focusing on the integration of clinical insights with payer policies to enhance the management of MS.



This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at

https://www.impactedu.net/ms-current-strategies. 

]]> 0:52:00 false IMPACT This PayerTalkCE episode provides an in-depth examination of the management and treatment of Multiple Sclerosis (MS) from both a clinical and payer perspective. Experts discuss various MS subtypes, emphasizing the importance of tailored treatments based on individual patient needs and disease progression. Key considerations include drug efficacy, side effects, comorbidities, and the economic aspects such as cost-effectiveness and payer coverage. The conversation highlights the challenges and strategies in optimizing treatment pathways, navigating benefit design complexities, and the potential of personalized medicine in improving patient outcomes. The discussion is highly relevant for health plan professionals, focusing on the integration of clinical insights with payer policies to enhance the management of MS.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.impactedu.net/ms-current-strategies (https://www.impactedu.net/psoriasis-advancements/).  PayerTalkCE™ Presents: Current Strategies to Optimize Clinical, Economic, and Humanistic Outcomes in Multiple Sclerosis 2 3 full 3 2 PayerTalkCE™ Presents: Balancing Cost and Access to Quality Care for Therapeutic Advancements in Psoriasis 2 https://www.impactedu.net/psoriasis-advancements/ https://blubrry.com/1469362/131735145/payertalkce-presents-balancing-cost-and-access-to-quality-care-for-therapeutic-advancements-in-psoriasis/ IMPACT Tue, 26 Mar 2024 00:00:00 -0400 Jim Kenney (formerly of Harvard Pilgrim) leads a discussion on advancements in psoriasis treatment, emphasizing the need for early diagnosis and tailored care, especially for skin of color patients who may face diagnostic delays. Joined by Dr. Heather Woolery-Lloyd (Johns Hopkins School of Medicine) and Jason Harris (National Psoriasis Foundation), the conversation covers the broad spectrum of psoriasis treatments, from topical therapies to biologics, and highlights the importance of considering patient preferences and comorbidities in treatment planning. They also discuss the challenges of access to care, the impact of psoriasis on mental health, and the evolving landscape of treatment options, emphasizing a multidisciplinary approach to manage this complex condition effectively.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/psoriasis-advancements/. 

]]> 0:45:51 false IMPACT Jim Kenney (formerly of Harvard Pilgrim) leads a discussion on advancements in psoriasis treatment, emphasizing the need for early diagnosis and tailored care, especially for skin of color patients who may face diagnostic delays. Joined by Dr. Heather Woolery-Lloyd (Johns Hopkins School of Medicine) and Jason Harris (National Psoriasis Foundation), the conversation covers the broad spectrum of psoriasis treatments, from topical therapies to biologics, and highlights the importance of considering patient preferences and comorbidities in treatment planning. They also discuss the challenges of access to care, the impact of psoriasis on mental health, and the evolving landscape of treatment options, emphasizing a multidisciplinary approach to manage this complex condition effectively.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/psoriasis-advancements/ (https://www.impactedu.net/psoriasis-advancements/).  PayerTalkCE™ Presents: Balancing Cost and Access to Quality Care for Therapeutic Advancements in Psoriasis 2 2 full 2 2 PayerTalkCE™ Presents: Addressing Unmet Needs in AMD and DME 1 https://www.managedcareeye.com/retinal-unmet-needs/ https://blubrry.com/1469362/128491966/payertalkce-presents-unmet-needs-in-amd-and-dme/ IMPACT Wed, 31 Jan 2024 00:00:00 -0500 Listen in as host Dr. Steve Kheloussi (Highmark, Inc) and guest Dr. Jordan Graff (BDP Eye Center) discuss unmet needs in age-related macular degeneration (AMD) and diabetic macular edema (DME). Among other topics their conversation covers the challenges of patient compliance due to treatment frequency, the role of payers in supporting innovative treatments, addressing the socio-economic factors affecting patient care, and the use of telemedicine and AI in improving access to care, especially in underserved areas.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/retinal-unmet-needs/. 

]]> 0:34:46 false IMPACT Listen in as host Dr. Steve Kheloussi (Highmark, Inc) and guest Dr. Jordan Graff (BDP Eye Center) discuss unmet needs in age-related macular degeneration (AMD) and diabetic macular edema (DME). Among other topics their conversation covers the challenges of patient compliance due to treatment frequency, the role of payers in supporting innovative treatments, addressing the socio-economic factors affecting patient care, and the use of telemedicine and AI in improving access to care, especially in underserved areas.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/retinal-unmet-needs/.  PayerTalkCE™ Presents: Addressing Unmet Needs in AMD and DME 2 1 full 18 https://assets.blubrry.com/coverart/episode/1469362/orig/128491966-1705513190.jpg 2 PayerTalkCE™ Presents: Achieving Appropriate and Equitable Treatment Access for Prostate Cancer Care 17 https://www.impactedu.net/prostate-podcast https://blubrry.com/1469362/127811095/payertalkce-presents-achieving-appropriate-and-equitable-treatment-access-for-prostate-cancer-care/ IMPACT Sat, 30 Dec 2023 00:00:00 -0500 This podcast features experts Dr. Christopher Fausel (Indiana University Simon Cancer Center), Jim Kenney (formerly Harvard Pilgrim), and Dr. Clayton Yates (Johns Hopkins School of Medicine) discussing strategies for achieving equitable treatment access for prostate cancer care. It emphasizes the significance of recognizing and addressing health disparities, particularly among Black men, who are disproportionately affected by prostate cancer. The conversation covers advancements in treatment options, including the impact of androgen deprivation therapy (ADT) and the potential of combination therapies to enhance outcomes. The speakers also highlight the importance of patient-provider communication, the role of precision medicine, and the need for systemic approaches to improve access and literacy in healthcare. Health plan professionals are encouraged to leverage data and engage in targeted interventions to mitigate disparities within their patient populations.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/rtcgmrecommendations/. 

]]> 0:54:47 false IMPACT This podcast features experts Dr. Christopher Fausel (Indiana University Simon Cancer Center), Jim Kenney (formerly Harvard Pilgrim), and Dr. Clayton Yates (Johns Hopkins School of Medicine) discussing strategies for achieving equitable treatment access for prostate cancer care. It emphasizes the significance of recognizing and addressing health disparities, particularly among Black men, who are disproportionately affected by prostate cancer. The conversation covers advancements in treatment options, including the impact of androgen deprivation therapy (ADT) and the potential of combination therapies to enhance outcomes. The speakers also highlight the importance of patient-provider communication, the role of precision medicine, and the need for systemic approaches to improve access and literacy in healthcare. Health plan professionals are encouraged to leverage data and engage in targeted interventions to mitigate disparities within their patient populations.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/rtcgmrecommendations/ (https://www.managedcarecgm.com/rtcgmrecommendations/).  PayerTalkCE™ Presents: Achieving Appropriate and Equitable Treatment Access for Prostate Cancer Care 1 17 full 17 https://assets.blubrry.com/coverart/episode/1469362/orig/127811095-1702493380.jpg 1 PayerTalkCE™ Presents: Innovations in the Retinal Disease Treatment Paradigm 16 https://www.managedcareeye.com/retinal-innovations/ https://blubrry.com/1469362/127808672/payertalkce-presents-innovations-in-the-retinal-disease-treatment-paradigm/ IMPACT Sat, 30 Dec 2023 00:00:00 -0500 Dive into the latest developments in retinal disease treatment with this podcast hosted by Dr. Steve Kheloussi (Highmark, Inc) who is joined by guest Dr. Ferhina Ali (New York Medical College). Listen to their dynamic conversation as they explore groundbreaking treatments and the impact of anti-VEGF therapy in transforming patient outcomes. From clinical trials to real-world applications, this podcast offers a comprehensive look at the advancements and challenges in managing retinal vascular diseases. Tune in now for a journey through the evolving landscape of retinal healthcare.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/retinalinnovations/. 

]]> 0:27:16 false IMPACT Dive into the latest developments in retinal disease treatment with this podcast hosted by Dr. Steve Kheloussi (Highmark, Inc) who is joined by guest Dr. Ferhina Ali (New York Medical College). Listen to their dynamic conversation as they explore groundbreaking treatments and the impact of anti-VEGF therapy in transforming patient outcomes. From clinical trials to real-world applications, this podcast offers a comprehensive look at the advancements and challenges in managing retinal vascular diseases. Tune in now for a journey through the evolving landscape of retinal healthcare.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/retinalinnovations/.  PayerTalkCE™ Presents: Innovations in the Retinal Disease Treatment Paradigm 1 16 full 16 https://assets.blubrry.com/coverart/episode/1469362/orig/127808672-1702485390.jpg 1 PayerTalkCE™ Presents: Improving the Utilization Management Process in Atopic Dermatitis 15 www.impactedu.net/managing-atopic-dermatitis https://blubrry.com/1469362/122476612/payertalkce-presents-improving-the-utilization-management-process-in-atopic-dermatitis/ IMPACT Thu, 30 Nov 2023 00:00:00 -0500 Join us for an insightful episode where expert faculty Dr. Gary M. Owens and Dana McCormick, RPh (BlueCross BlueShield Texas), discuss comprehensive conversation about atopic dermatitis (AD). They explore innovative strategies to enhance access to treatment and navigate the complexities of payer benefit management. This episode is crucial for understanding the evolving landscape of AD therapies, including injectables and oral treatments that have emerged as game-changers in patient care. The dialogue examines the challenges of balancing cost-effective care with ensuring patients receive timely and appropriate treatment. Through their expert insights, Dr. Owens and Ms. McCormick shed light on the critical role of utilization management in optimizing healthcare resources while prioritizing patient well-being.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/managing-atopic-dermatitis/. 

]]> 0:25:48 false IMPACT Join us for an insightful episode where expert faculty Dr. Gary M. Owens and Dana McCormick, RPh (BlueCross BlueShield Texas), discuss comprehensive conversation about atopic dermatitis (AD). They explore innovative strategies to enhance access to treatment and navigate the complexities of payer benefit management. This episode is crucial for understanding the evolving landscape of AD therapies, including injectables and oral treatments that have emerged as game-changers in patient care. The dialogue examines the challenges of balancing cost-effective care with ensuring patients receive timely and appropriate treatment. Through their expert insights, Dr. Owens and Ms. McCormick shed light on the critical role of utilization management in optimizing healthcare resources while prioritizing patient well-being. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/managing-atopic-dermatitis/ (https://www.impactedu.net/managing-atopic-dermatitis/).  PayerTalkCE™ Presents: Improving the Utilization Management Process in Atopic Dermatitis 1 15 full 15 https://assets.blubrry.com/coverart/episode/1469362/orig/122476612-1700600814.jpg 1 PayerTalkCE™ Presents: Impact of An Aging US Population on Retinal Diseases 14 https://www.managedcareeye.com/aging-retinal-diseases https://blubrry.com/1469362/122338638/payertalkce-presents-impact-of-an-aging-us-population-on-retinal-diseases/ IMPACT Thu, 30 Nov 2023 00:00:00 -0500 Join us for this thought-provoking episode hosted by Dr. Jeff Dunn (Cooperative Benefits Group) with special guest Dr. Garvin Davis (Methodist Eye Associates). Learn about the critical discussions surrounding the escalating challenges and costs associated with managing retinal diseases like age-related macular degeneration and diabetic retinopathy in an aging population. Explore the advancements in treatment, the role of socioeconomic factors, and the complex interplay between healthcare providers and insurance policies in delivering patient care. This podcast offers invaluable insights into the future of ophthalmic care and the importance of preserving vision in an aging society.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/aging-retinal-diseases/. 

]]> 0:30:30 false IMPACT Join us for this thought-provoking episode hosted by Dr. Jeff Dunn (Cooperative Benefits Group) with special guest Dr. Garvin Davis (Methodist Eye Associates). Learn about the critical discussions surrounding the escalating challenges and costs associated with managing retinal diseases like age-related macular degeneration and diabetic retinopathy in an aging population. Explore the advancements in treatment, the role of socioeconomic factors, and the complex interplay between healthcare providers and insurance policies in delivering patient care. This podcast offers invaluable insights into the future of ophthalmic care and the importance of preserving vision in an aging society. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/aging-retinal-diseases/.  PayerTalkCE™ Presents: Impact of An Aging US Population on Retinal Diseases 1 14 full 14 https://assets.blubrry.com/coverart/episode/1469362/orig/122338638-1699473597.jpg 1 PayerTalkCE™ Presents: Continuous Glucose Monitoring: Improving Access to CGM Under the Pharmacy Benefit 13 https://www.managedcarecgm.com/cgm-access-podcast https://blubrry.com/1469362/120876720/payertalkce-presents-continuous-glucose-monitoring-improving-access-to-cgm-under-the-pharmacy-benefit/ IMPACT Tue, 31 Oct 2023 00:00:00 -0400 In this insightful episode, Dr. Jeff Dunn (Cooperative Benefits Group) and Janelle Grubbs (Kroger Prescription Plans) engage in a compelling discussion on the utilization management of continuous glucose monitoring (CGM) under the pharmacy benefit. They delve into how Kroger Prescription Plans has pioneered open access to CGM, eliminating prior authorizations and streamlining access for both type 1 and type 2 diabetes patients. The dialogue covers the rationale behind this strategic move, the impact on patient and provider satisfaction, and the broader implications for healthcare coverage and wellness programming. This episode is essential for health plan professionals looking to understand the evolving landscape of diabetes management and the benefits of enhanced access to CGM.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/cgm-access-podcast/.

]]> 0:27:33 false IMPACT In this insightful episode, Dr. Jeff Dunn (Cooperative Benefits Group) and Janelle Grubbs (Kroger Prescription Plans) engage in a compelling discussion on the utilization management of continuous glucose monitoring (CGM) under the pharmacy benefit. They delve into how Kroger Prescription Plans has pioneered open access to CGM, eliminating prior authorizations and streamlining access for both type 1 and type 2 diabetes patients. The dialogue covers the rationale behind this strategic move, the impact on patient and provider satisfaction, and the broader implications for healthcare coverage and wellness programming. This episode is essential for health plan professionals looking to understand the evolving landscape of diabetes management and the benefits of enhanced access to CGM.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/cgm-access-podcast/ (https://www.managedcarecgm.com/cgm-access-podcast/). PayerTalkCE™ Presents: Continuous Glucose Monitoring: Improving Access to CGM Under the Pharmacy Benefit 1 13 full 13 https://assets.blubrry.com/coverart/episode/1469362/orig/120876720-1698098063.jpg 1 PayerTalkCE™ Presents: Access and Utilization Strategies for the Management EoE 12 www.impactedu.net/eoe-strategies-podcast https://blubrry.com/1469362/120778987/payertalkce-presents-access-and-utilization-strategies-for-the-management-eoe/ IMPACT Tue, 31 Oct 2023 00:00:00 -0400 Explore the complexities of eosinophilic esophagitis (EoE) management with Fredric S. Goldstein (Accountable Health, LLC) and Dr. Steve Kheloussi, PharmD, MBA, FAMCP (Highmark Inc.). This episode sheds light on the patient journey, the importance of early diagnosis, the multidisciplinary approach to care, and the evolving landscape of treatment options. With insights on benefit design strategies and payer roles in improving outcomes, this discussion is a valuable resource for healthcare professionals seeking to enhance the quality of life for patients with EoE. Tune in to gain a deeper understanding of how collaborative care and informed access strategies are pivotal in the effective management of eosinophilic esophagitis.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/eoe-strategies-podcast/..

]]> 0:29:03 false IMPACT Explore the complexities of eosinophilic esophagitis (EoE) management with Fredric S. Goldstein (Accountable Health, LLC) and Dr. Steve Kheloussi, PharmD, MBA, FAMCP (Highmark Inc.). This episode sheds light on the patient journey, the importance of early diagnosis, the multidisciplinary approach to care, and the evolving landscape of treatment options. With insights on benefit design strategies and payer roles in improving outcomes, this discussion is a valuable resource for healthcare professionals seeking to enhance the quality of life for patients with EoE. Tune in to gain a deeper understanding of how collaborative care and informed access strategies are pivotal in the effective management of eosinophilic esophagitis.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/eoe-strategies-podcast/ (https://www.impactedu.net/eoe-strategies-podcast/).. PayerTalkCE™ Presents: Access and Utilization Strategies for the Management EoE 1 12 full 12 1 PayerTalkCE™ Presents: Understanding Best Practices in Access to Pediatric Dermatologic Care for Children Living with Atopic Dermatitis 11 www.impactedu.net/atopic-dermatitis-payertalk https://blubrry.com/1469362/118834493/payertalkce-presents-understanding-best-practices-in-access-to-pediatric-dermatologic-care-for-children-living-with-atopic-dermatitis/ IMPACT Sun, 01 Oct 2023 00:00:00 -0400 Tune in for a compelling episode of PayerTalkCE™ hosted by Dr. Gary M. Owens and featuring the insights of Dr. Joy Wan (Johns Hopkins University School of Medicine). This session considers the critical aspects of pediatric dermatology, focusing on atopic dermatitis (AD). Dr. Wan shares her extensive experience in treating a diverse range of pediatric patients, from initial diagnosis to managing complex, severe cases. The conversation navigates through the challenges of accessing specialized care, the importance of a detailed patient assessment, and the impact of AD beyond skin symptoms, emphasizing the profound effect on quality of life and mental health. With a growing arsenal of effective treatments transforming patient care, this episode highlights the necessity for managed care professionals to understand the intricacies of AD in children and the importance of facilitating timely and appropriate access to life-changing therapies.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopic-dermatitis-payertalk/.



]]> 0:30:00 false IMPACT Tune in for a compelling episode of PayerTalkCE™ hosted by Dr. Gary M. Owens and featuring the insights of Dr. Joy Wan (Johns Hopkins University School of Medicine). This session considers the critical aspects of pediatric dermatology, focusing on atopic dermatitis (AD). Dr. Wan shares her extensive experience in treating a diverse range of pediatric patients, from initial diagnosis to managing complex, severe cases. The conversation navigates through the challenges of accessing specialized care, the importance of a detailed patient assessment, and the impact of AD beyond skin symptoms, emphasizing the profound effect on quality of life and mental health. With a growing arsenal of effective treatments transforming patient care, this episode highlights the necessity for managed care professionals to understand the intricacies of AD in children and the importance of facilitating timely and appropriate access to life-changing therapies.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopic-dermatitis-payertalk/ (https://www.impactedu.net/atopic-dermatitis-payertalk/). PayerTalkCE™ Presents: Understanding Best Practices in Access to Pediatric Dermatologic Care for Children Living with Atopic Dermatitis 1 11 full 11 1 PayerTalkCE™ Presents: Major Advances in the Management of Retinopathy of Prematurity (ROP) 10 www.managedcareeye.com/ropcepodcast/ https://blubrry.com/1469362/118768079/payertalkce-presents-major-advances-in-the-management-of-retinopathy-of-prematurity-rop/ IMPACT Sat, 30 Sep 2023 00:00:00 -0400 Step into the realm of groundbreaking strides in the battle against retinopathy of prematurity (ROP) in this PayerTalkCE episode. Hosted by Dr. Jeff Dunn (Cooperative Benefits Group), this episode features an enlightening conversation with Dr. Edward Wood (Austin Retina Associates), an expert in pediatric retinal diseases. As they delve into the complexities of ROP—a condition that poses a significant threat to the vision of premature infants—the duo sheds light on the critical importance of timely and accurate screening, diagnosis, and intervention. With insightful discussions on the nuances of treatment options, including the pivotal role of anti-VEGF therapy and laser treatments, this episode is a must-listen for healthcare professionals striving to safeguard the vision of our youngest and most vulnerable patients.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/ropcepodcast/.

.

]]> 0:29:13 false IMPACT Step into the realm of groundbreaking strides in the battle against retinopathy of prematurity (ROP) in this PayerTalkCE episode. Hosted by Dr. Jeff Dunn (Cooperative Benefits Group), this episode features an enlightening conversation with Dr. Edward Wood (Austin Retina Associates), an expert in pediatric retinal diseases. As they delve into the complexities of ROP—a condition that poses a significant threat to the vision of premature infants—the duo sheds light on the critical importance of timely and accurate screening, diagnosis, and intervention. With insightful discussions on the nuances of treatment options, including the pivotal role of anti-VEGF therapy and laser treatments, this episode is a must-listen for healthcare professionals striving to safeguard the vision of our youngest and most vulnerable patients. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/ropcepodcast/.. PayerTalkCE™ Presents: Major Advances in the Management of Retinopathy of Prematurity (ROP) 1 10 full 10 https://assets.blubrry.com/coverart/episode/1469362/orig/118768079-1694716780.jpg 1 PayerTalkCE Presents: Managing Eosinophilic Esophagitis (EoE): Collaborative Care and the Patient Journey 9 www.impactedu.net/payertalkjourney https://blubrry.com/1469362/111220862/payertalkce-presents-managing-eosinophilic-esophagitis-eoe-collaborative-care-and-the-patient-journey/ IMPACT Tue, 15 Aug 2023 00:00:00 -0400 Embark on an enlightening journey through the complex world of eosinophilic esophagitis (EoE) management. Join host Dr. Steve Kheloussi (Highmark, Inc.), alongside experts Mary Jo Strobel (American Partnership for Eosinophilic Disorders, and Dr. Evan Dellon (University of North Carolina at Chapel Hill), as they unravel the intricacies of the patient journey with EoE. This episode delves deep into the challenges of diagnosing EoE, the significant impact of delayed diagnosis, and the innovative approaches to collaborative care. Discover the evolving recommendations that are shaping the future of EoE management and how multidisciplinary teams are working to improve outcomes for patients. This insightful discussion offers a comprehensive look at the efforts to enhance the quality of life for those affected by EoE, emphasizing the importance of timely intervention and ongoing monitoring.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/payertalkjourney/.

]]> 0:28:33 false IMPACT Embark on an enlightening journey through the complex world of eosinophilic esophagitis (EoE) management. Join host Dr. Steve Kheloussi (Highmark, Inc.), alongside experts Mary Jo Strobel (American Partnership for Eosinophilic Disorders, and Dr. Evan Dellon (University of North Carolina at Chapel Hill), as they unravel the intricacies of the patient journey with EoE. This episode delves deep into the challenges of diagnosing EoE, the significant impact of delayed diagnosis, and the innovative approaches to collaborative care. Discover the evolving recommendations that are shaping the future of EoE management and how multidisciplinary teams are working to improve outcomes for patients. This insightful discussion offers a comprehensive look at the efforts to enhance the quality of life for those affected by EoE, emphasizing the importance of timely intervention and ongoing monitoring.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/payertalkjourney/ (https://www.impactedu.net/payertalkjourney/). PayerTalkCE Presents: Managing Eosinophilic Esophagitis (EoE): Collaborative Care and the Patient Journey 1 9 full 9 https://assets.blubrry.com/coverart/episode/1469362/orig/111220862-1691417549.jpg 1 PayerTalkCE Presents: Interpreting A Complex Puzzle: US Commercial Payer Coverage of Atopic Dermatitis (AD) Treatments Varies Widely 8 https://www.impactedu.net/atopicdermtreatments https://blubrry.com/1469362/109721988/payertalkce-presents-interpreting-a-complex-puzzle-us-commercial-payer-coverage-of-atopic-dermatitis-ad-treatments-varies-widely/ IMPACT Mon, 31 Jul 2023 00:01:00 -0400 In this episode Dr. Steve Kheloussi (Highmark) engages in a fascinating discussion with Dr. James Chambers (Tufts Medical Center). They explore the intricate world of commercial health plans' coverage decisions for atopic dermatitis treatments in the US. Dr. Chambers provides insights from his extensive research into how various payers are navigating the rapidly evolving treatment landscape for AD, particularly with the advent of specialty therapies like biologics. This conversation sheds light on the significant variability in coverage policies, the evolution of these policies over time, and the impact on patient access to critical treatments. Health plan professionals will gain a deeper understanding of the challenges and considerations in formulating coverage policies for AD treatments, emphasizing the need for evidence-based decision-making and the potential implications for patient care and outcomes.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermtreatments/.

]]> 0:30:22 false IMPACT In this episode Dr. Steve Kheloussi (Highmark) engages in a fascinating discussion with Dr. James Chambers (Tufts Medical Center). They explore the intricate world of commercial health plans' coverage decisions for atopic dermatitis treatments in the US. Dr. Chambers provides insights from his extensive research into how various payers are navigating the rapidly evolving treatment landscape for AD, particularly with the advent of specialty therapies like biologics. This conversation sheds light on the significant variability in coverage policies, the evolution of these policies over time, and the impact on patient access to critical treatments. Health plan professionals will gain a deeper understanding of the challenges and considerations in formulating coverage policies for AD treatments, emphasizing the need for evidence-based decision-making and the potential implications for patient care and outcomes. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermtreatments/ (https://www.impactedu.net/atopicdermtreatments/). PayerTalkCE Presents: Interpreting A Complex Puzzle: US Commercial Payer Coverage of Atopic Dermatitis (AD) Treatments Varies Widely 1 8 full 8 https://www.impactedu.net/images/PTceEp8_EpImage.jpg 1 PayerTalkCE Presents: Access and Utilization Strategies for the Management of Specialty Drugs in Atopic Dermatitis 7 https://www.impactedu.net/atopicdermstrategies https://blubrry.com/1469362/102625548/payertalkce-presents-access-and-utilization-strategies-for-the-management-of-specialty-drugs-in-atopic-dermatitis/ IMPACT Fri, 30 Jun 2023 00:01:00 -0400 Dr. Steve Kheloussi (Highmark, Inc.) and Dana McCormick (BlueCross BlueShield Texas) delve into the complexities health plans face in managing treatments for atopic dermatitis. They explore innovative treatment options that have recently become available, the impact of these treatments on patient quality of life, and strategies health plans can implement to enhance patient outcomes. The conversation highlights the challenges in designing benefits to ensure timely access to evidence-based treatments, the lag in clinical guidelines following rapid advancements in therapy options, and the administrative hurdles that can impede patient care. The faculty also discuss the importance of payer-provider collaboration in addressing these issues and the potential for technology to streamline access and reduce administrative burdens. This discussion is essential for health plan professionals looking to navigate the intricacies of providing coverage for atopic dermatitis treatments effectively.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermstrategies/.

]]> 0:24:19 false IMPACT Dr. Steve Kheloussi (Highmark, Inc.) and Dana McCormick (BlueCross BlueShield Texas) delve into the complexities health plans face in managing treatments for atopic dermatitis. They explore innovative treatment options that have recently become available, the impact of these treatments on patient quality of life, and strategies health plans can implement to enhance patient outcomes. The conversation highlights the challenges in designing benefits to ensure timely access to evidence-based treatments, the lag in clinical guidelines following rapid advancements in therapy options, and the administrative hurdles that can impede patient care. The faculty also discuss the importance of payer-provider collaboration in addressing these issues and the potential for technology to streamline access and reduce administrative burdens. This discussion is essential for health plan professionals looking to navigate the intricacies of providing coverage for atopic dermatitis treatments effectively. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermstrategies/ (https://www.impactedu.net/atopicdermstrategies/). PayerTalkCE Presents: Access and Utilization Strategies for the Management of Specialty Drugs in Atopic Dermatitis 1 7 full 7 https://www.impactedu.net/images/PTceEp7_EpImage.jpg 1 PayerTalkCE Presents: Tackling the Clinical, Economic, and Humanistic Burden of Atopic Dermatitis 6 https://www.impactedu.net/atopicdermburden/ https://blubrry.com/1469362/94400703/payertalkce-presents-tackling-the-clinical-economic-and-humanistic-burden-of-atopic-dermatitis/ IMPACT Mon, 20 Mar 2023 00:01:00 -0400 In this award-winning episode hosted by Dr. Steven Kheloussi (Highmark, Inc.) and featuring guest Ashley Ellis (National Eczema Association), the dialogue revolves around the multifaceted challenges presented by atopic dermatitis. Ashley shares her personal journey as a mother of a child with atopic dermatitis, providing insights into the patient and caregiver experience. The discussion covers the clinical management of the condition, its economic implications for families, and the broader humanistic impact on patients' lives, emphasizing the need for empathy and understanding in healthcare interactions. The conversation also touches on the importance of effective patient-provider communication, the potential benefits of newer treatment options, and the complexities involved in navigating health insurance systems to access necessary care.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermburden/. 

]]> 0:34:44 false IMPACT In this award-winning episode hosted by Dr. Steven Kheloussi (Highmark, Inc.) and featuring guest Ashley Ellis (National Eczema Association), the dialogue revolves around the multifaceted challenges presented by atopic dermatitis. Ashley shares her personal journey as a mother of a child with atopic dermatitis, providing insights into the patient and caregiver experience. The discussion covers the clinical management of the condition, its economic implications for families, and the broader humanistic impact on patients' lives, emphasizing the need for empathy and understanding in healthcare interactions. The conversation also touches on the importance of effective patient-provider communication, the potential benefits of newer treatment options, and the complexities involved in navigating health insurance systems to access necessary care. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermburden/ (https://www.impactedu.net/atopicdermburden/).  PayerTalkCE Presents: Tackling the Clinical, Economic, and Humanistic Burden of Atopic Dermatitis 1 6 full https://www.impactedu.net/images/PTceEp6_EpImage.jpg 1 PayerTalkCE Presents: Real-time Continuous Glucose Monitoring Impact on Glycemic Control and Acute Metabolic Events 5 https://www.managedcarecgm.com/impactpayertalk https://blubrry.com/1469362/93690288/payertalkce-presents-real-time-continuous-glucose-monitoring-impact-on-glycemic-control-and-acute-metabolic-events/ IMPACT Tue, 28 Feb 2023 00:01:00 -0500 This podcast features discussions on the impact of real-time continuous glucose monitoring (CGM) on glycemic control and acute metabolic events among insulin-treated diabetes patients. Dr. Jeffrey Dunn (Cooperative Benefits Group) and Dr. Richard Dlott (formerly The Permanente Medical Group (TPMG) / Kaiser Permanente Northern California) look at the findings of a recent study published in JAMA, which observed significant benefits of CGM in both type 1 and type 2 diabetes patients, including notable A1c reductions and decreased emergency room visits for hypoglycemia. They emphasize the importance of patient engagement in diabetes management and explore the implications of new CMS quality measures for 2023 on health plans. The conversation highlights the potential for CGM to transform diabetes care by providing real-time data that can empower patients and inform treatment decisions, underscoring the need for health plans to consider broader access to this technology.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/impactpayertalk/. 

]]> 0:27:49 false IMPACT This podcast features discussions on the impact of real-time continuous glucose monitoring (CGM) on glycemic control and acute metabolic events among insulin-treated diabetes patients. Dr. Jeffrey Dunn (Cooperative Benefits Group) and Dr. Richard Dlott (formerly The Permanente Medical Group (TPMG) / Kaiser Permanente Northern California) look at the findings of a recent study published in JAMA, which observed significant benefits of CGM in both type 1 and type 2 diabetes patients, including notable A1c reductions and decreased emergency room visits for hypoglycemia. They emphasize the importance of patient engagement in diabetes management and explore the implications of new CMS quality measures for 2023 on health plans. The conversation highlights the potential for CGM to transform diabetes care by providing real-time data that can empower patients and inform treatment decisions, underscoring the need for health plans to consider broader access to this technology.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/impactpayertalk/ (https://www.managedcarecgm.com/impactpayertalk/).  PayerTalkCE Presents: Real-time Continuous Glucose Monitoring Impact on Glycemic Control and Acute Metabolic Events 1 5 full https://www.impactedu.net/images/PTceEp5_EpImage.jpg 1 PayerTalkCE Presents: Health Plan Strategies for Quality Improvement in Underserved Populations with Diabetes 4 https://www.managedcarecgm.com/cgmqualitypayertalk https://blubrry.com/1469362/93175770/payertalkce-presents-health-plan-strategies-for-quality-improvement-in-underserved-populations-with-diabetes/ IMPACT Fri, 10 Feb 2023 00:01:00 -0500 In this podcast, Dr. Jeff Dunn (Cooperative Benefits Group) and Estay Greene, PharmD, MBA (Zing Health), explore effective strategies for enhancing diabetes care among underserved populations, particularly the elderly. They discuss the importance of addressing hypoglycemia risks and the integration of continuous glucose monitoring (CGM) to improve patient outcomes. The dialogue sheds light on the challenge of balancing cost-effective treatment with the safety and efficacy of diabetes management, emphasizing the need for health plans to adapt to innovative technologies and education for better patient engagement. They highlight how Zing Health is pioneering in providing CGM devices at no cost to members and the impact of recent CMS coverage changes on diabetes care. The session concludes with insights into tackling technology gaps in elderly patients and addressing disparities in diabetes treatment across different demographics.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/cgmqualitypayertalk/.

]]> 0:28:56 false IMPACT In this podcast, Dr. Jeff Dunn (Cooperative Benefits Group) and Estay Greene, PharmD, MBA (Zing Health), explore effective strategies for enhancing diabetes care among underserved populations, particularly the elderly. They discuss the importance of addressing hypoglycemia risks and the integration of continuous glucose monitoring (CGM) to improve patient outcomes. The dialogue sheds light on the challenge of balancing cost-effective treatment with the safety and efficacy of diabetes management, emphasizing the need for health plans to adapt to innovative technologies and education for better patient engagement. They highlight how Zing Health is pioneering in providing CGM devices at no cost to members and the impact of recent CMS coverage changes on diabetes care. The session concludes with insights into tackling technology gaps in elderly patients and addressing disparities in diabetes treatment across different demographics.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/cgmqualitypayertalk/ (https://www.managedcarecgm.com/cgmqualitypayertalk/). PayerTalkCE Presents: Health Plan Strategies for Quality Improvement in Underserved Populations with Diabetes 1 4 full https://www.impactedu.net/images/PTceEp4_EpImage.jpg 1 PayerTalkCE Presents: Health Plan Implementation Recommendations for rtCGM 3 https://www.managedcarecgm.com/rtcgmrecommendations http://www.blubrry.com/1469362/91782887/payertalkce-presents-health-plan-implementation-recommendations-for-rtcgm/ IMPACT Wed, 14 Dec 2022 00:01:00 -0500 In this award-winning podcast, Dr. Roy Gandolfi (SelectHealth) and Dr. Jeff Dunn (Cooperative Benefits Group) discuss the integration and benefits of real-time continuous glucose monitoring (rtCGM) in managing diabetes, particularly through Medicare Advantage. They examine the clinical evidence supporting rtCGM's role in improving patient outcomes, adherence to ADA guidelines, and recent CMS local coverage determination criteria updates facilitating broader rtCGM access. The conversation emphasizes rtCGM's potential in enhancing patient engagement, reducing healthcare costs, and improving quality metrics. A Q&A session with the audience addresses CMS changes, health plan coverage, and identifying rtCGM candidates, underscoring the technology's growing impact on diabetes care.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/rtcgmrecommendations/. 

]]> 0:27:42 false IMPACT In this award-winning podcast, Dr. Roy Gandolfi (SelectHealth) and Dr. Jeff Dunn (Cooperative Benefits Group) discuss the integration and benefits of real-time continuous glucose monitoring (rtCGM) in managing diabetes, particularly through Medicare Advantage. They examine the clinical evidence supporting rtCGM's role in improving patient outcomes, adherence to ADA guidelines, and recent CMS local coverage determination criteria updates facilitating broader rtCGM access. The conversation emphasizes rtCGM's potential in enhancing patient engagement, reducing healthcare costs, and improving quality metrics. A Q&A session with the audience addresses CMS changes, health plan coverage, and identifying rtCGM candidates, underscoring the technology's growing impact on diabetes care.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/rtcgmrecommendations/ (https://www.managedcarecgm.com/rtcgmrecommendations/).  PayerTalkCE Presents: Health Plan Implementation Recommendations for rtCGM 1 3 full https://www.impactedu.net/images/PTceEp2_EpImage.jpg 1 PayerTalkCE Presents: The Rapidly Evolving Atopic Dermatitis Treatment Paradigm 2 https://www.impactedu.net/atopicdermpayertalk http://www.blubrry.com/1469362/92048954/payertalkce-presents-the-rapidly-evolving-atopic-dermatitis-treatment-paradigm/ IMPACT Mon, 12 Dec 2022 00:01:00 -0500 In this PayerTalkCE" podcast join host Dr. Steve Kheloussi (Highmark, Inc.) and guest Dr. Adam Friedman (The George Washington University School of Medicine and Health Sciences) and listen as their discussion explores the significant advancements in the treatment of atopic dermatitis. Dr. Friedman shares insights into the disease's complexities, its impact on quality of life, and the innovative therapies transforming patient care. The conversation delves into the challenges and opportunities health plans face in integrating these new treatments, emphasizing the need for personalized care and equitable access. This episode is an invaluable resource for health plan professionals seeking to enhance their understanding of atopic dermatitis and its evolving treatment landscape.


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermpayertalk/.

]]> 0:36:53 false IMPACT In this PayerTalkCE" podcast join host Dr. Steve Kheloussi (Highmark, Inc.) and guest Dr. Adam Friedman (The George Washington University School of Medicine and Health Sciences) and listen as their discussion explores the significant advancements in the treatment of atopic dermatitis. Dr. Friedman shares insights into the disease's complexities, its impact on quality of life, and the innovative therapies transforming patient care. The conversation delves into the challenges and opportunities health plans face in integrating these new treatments, emphasizing the need for personalized care and equitable access. This episode is an invaluable resource for health plan professionals seeking to enhance their understanding of atopic dermatitis and its evolving treatment landscape.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermpayertalk/ (https://www.impactedu.net/atopicdermpayertalk/). PayerTalkCE Presents: The Rapidly Evolving Atopic Dermatitis Treatment Paradigm 1 2 full https://www.impactedu.net/images/PTceEp3_EpImage.jpg 1 PayerTalkCE Presents: Applying Real-World Experience to Better Manage the Use of Oncology Biosimilars 1 https://www.impactedu.net/biosimpayertalk http://www.blubrry.com/1469362//payertalkce-presents-applying-real-world-experience-to-better-manage-the-use-of-oncology-biosimilars/ IMPACT Tue, 15 Nov 2022 00:01:00 -0500 This award-winning podcast explores the intricacies of managing and adopting oncology biosimilars, highlighting their crucial role in delivering cost-effective cancer care. The discussion involves experts who examine the regulatory landscape, share insights from real-world evidence, and discuss the clinical implications of biosimilars. Key topics include their efficacy, safety, and interchangeability. The conversation also covers the challenges and strategies for incorporating biosimilars into healthcare systems, emphasizing the need for education, policy adjustments, and practice adaptations. This dialogue aims to enhance health plan professionals' understanding and confidence in biosimilars, underlining their potential to expand patient access to treatments while achieving substantial healthcare savings. Featured faculty include Dr. Raj Duggal (Indiana University Health), Jim Kenney (formerly Harvard Pilgrim), and Dr. Cate Lockhart (Biologics and Biosimilars Collective Intelligence Consortium).


This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/biosimpayertalk/. 

]]> 0:48:10 false IMPACT This award-winning podcast explores the intricacies of managing and adopting oncology biosimilars, highlighting their crucial role in delivering cost-effective cancer care. The discussion involves experts who examine the regulatory landscape, share insights from real-world evidence, and discuss the clinical implications of biosimilars. Key topics include their efficacy, safety, and interchangeability. The conversation also covers the challenges and strategies for incorporating biosimilars into healthcare systems, emphasizing the need for education, policy adjustments, and practice adaptations. This dialogue aims to enhance health plan professionals' understanding and confidence in biosimilars, underlining their potential to expand patient access to treatments while achieving substantial healthcare savings. Featured faculty include Dr. Raj Duggal (Indiana University Health), Jim Kenney (formerly Harvard Pilgrim), and Dr. Cate Lockhart (Biologics and Biosimilars Collective Intelligence Consortium).This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/biosimpayertalk/ (https://www.impactedu.net/biosimpayertalk/).  PayerTalkCE Presents: Applying Real-World Experience to Better Manage the Use of Oncology Biosimilars 1 1 full 1 https://www.impactedu.net/images/PTceEp1_EpImage.jpg 1